| Daniel Gk Phillips, MD | |
|
305 Park Creek Dr, Clovis, CA 93611-4426 | |
| (559) 326-2800 | |
| (559) 326-2801 |
| Full Name | Daniel Gk Phillips |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 18 Years |
| Location | 305 Park Creek Dr, Clovis, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144344003 | NPI | - | NPPES |
| LAB44024F | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0101X | Pathology - Anatomic Pathology | A111207 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Regional Medical Center | Fresno, CA | Hospital |
| Clovis Community Medical Center | Clovis, CA | Hospital |
| Adventist Health Hanford | Hanford, CA | Hospital |
| Fresno Surgical Hospital | Fresno, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pathology Associates | 9133168784 | 16 |
News Archive
Results of a phase 1 clinical trial reported at the American Association for Cancer Research (AACR) annual conference show that orally administered Rigosertib is well tolerated in patients with advanced solid tumors.
Aggressive treatment of anemia with intravenous iron and drugs known as erythropoiesis-stimulating agents (ESAs) may lower the risk of death for dialysis patients with severe anemia - but also may increase the risk of death among patients with milder anemia, a new study led by a University of North Carolina at Chapel Hill epidemiologist suggests.
Henry Ford Health System is first in the country to enroll a patient in the Human Epidemiology and Response to SARS-CoV-2 study, which aims to help determine the rate of SARS-CoV-2, the virus that causes COVID-19, among U.S. children and their family members, and what percentage of children infected with SARS-CoV-2 develop symptoms of the disease.
A National Institutes of Health-funded study found that people with substance use disorders (SUDs) are more susceptible to COVID-19 and its complications.
› Verified 8 days ago
| Entity Name | Pathology Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144277633 PECOS PAC ID: 9133168784 Enrollment ID: O20050503000488 |
News Archive
Results of a phase 1 clinical trial reported at the American Association for Cancer Research (AACR) annual conference show that orally administered Rigosertib is well tolerated in patients with advanced solid tumors.
Aggressive treatment of anemia with intravenous iron and drugs known as erythropoiesis-stimulating agents (ESAs) may lower the risk of death for dialysis patients with severe anemia - but also may increase the risk of death among patients with milder anemia, a new study led by a University of North Carolina at Chapel Hill epidemiologist suggests.
Henry Ford Health System is first in the country to enroll a patient in the Human Epidemiology and Response to SARS-CoV-2 study, which aims to help determine the rate of SARS-CoV-2, the virus that causes COVID-19, among U.S. children and their family members, and what percentage of children infected with SARS-CoV-2 develop symptoms of the disease.
A National Institutes of Health-funded study found that people with substance use disorders (SUDs) are more susceptible to COVID-19 and its complications.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Gk Phillips, MD 305 Park Creek Dr, Clovis, CA 93611-4426 Ph: (559) 326-2800 | Daniel Gk Phillips, MD 305 Park Creek Dr, Clovis, CA 93611-4426 Ph: (559) 326-2800 |
News Archive
Results of a phase 1 clinical trial reported at the American Association for Cancer Research (AACR) annual conference show that orally administered Rigosertib is well tolerated in patients with advanced solid tumors.
Aggressive treatment of anemia with intravenous iron and drugs known as erythropoiesis-stimulating agents (ESAs) may lower the risk of death for dialysis patients with severe anemia - but also may increase the risk of death among patients with milder anemia, a new study led by a University of North Carolina at Chapel Hill epidemiologist suggests.
Henry Ford Health System is first in the country to enroll a patient in the Human Epidemiology and Response to SARS-CoV-2 study, which aims to help determine the rate of SARS-CoV-2, the virus that causes COVID-19, among U.S. children and their family members, and what percentage of children infected with SARS-CoV-2 develop symptoms of the disease.
A National Institutes of Health-funded study found that people with substance use disorders (SUDs) are more susceptible to COVID-19 and its complications.
› Verified 8 days ago
Baorong Chen, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 305 Park Creek Dr, Clovis, CA 93611 Phone: 559-326-2815 Fax: 559-326-2815 | |
Stevan Knezevich, Pathology Medicare: Accepting Medicare Assignments Practice Location: 305 Park Creek Dr, Clovis, CA 93611 Phone: 559-326-2800 | |
Paul H Atmajian, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 305 Park Creek Dr, Clovis, CA 93611 Phone: 559-326-2815 Fax: 559-326-2801 | |
Robert M Futoran, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 305 Park Creek Dr, Clovis, CA 93611 Phone: 559-326-2815 Fax: 559-326-2801 | |
Dr. Roberto Alvaro Allam Taguibao, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 305 Park Creek Dr, Clovis, CA 93611 Phone: 559-326-2800 Fax: 559-326-2801 | |
John Steven Pollard, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 305 Park Creek Dr, Clovis, CA 93611 Phone: 559-326-2815 Fax: 559-326-2801 |